Insider Stock Trading History of Goeltz Ii Robert C.


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Goeltz Ii Robert C. since year 2005. The trader's CIK number is 1653881. At the time of this reporting, Goeltz Ii Robert C. is the Chief Financial Officer of Unity Biotechnology, Inc. . (stock ticker symbol UBX). See this page for all insider trading activities at Unity Biotechnology, Inc. .

Note that in the past Goeltz II Robert C. also reported insider trading activities as an insider of the following companies:
Stock purchases, sales, and option exercises reported by insider Goeltz Ii Robert C. since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2018-10-10 UBX Unity Biotechnology, Inc. Option Ex 5,000 3.43 17,150
2017-05-12 CTMX Cytomx Therapeutics, Inc. Option Ex 19,967 5.54 110,697
2017-04-10 CTMX Cytomx Therapeutics, Inc. Option Ex 3,000 4.47 13,419
2017-03-20 CTMX Cytomx Therapeutics, Inc. Sale 21,517 19.80 426,036
2017-03-20 CTMX Cytomx Therapeutics, Inc. Option Ex 21,517 4.47 96,245
2017-03-09 CTMX Cytomx Therapeutics, Inc. Option Ex 2,500 4.47 11,182
2016-09-29 CTMX Cytomx Therapeutics, Inc. Option Ex 4,000 4.47 17,892
2016-05-12 CTMX Cytomx Therapeutics, Inc. Option Ex 2,000 4.47 8,946

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Goeltz Ii Robert C. (Chief Financial Officer of Unity Biotechnology, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.